Healthcare and preventive services utilization of elderly Europeans with depressive symptoms by Peytremann Bridevaux, Isabelle et al.
 
Peytremann-Bridevaux I, Voellinger R, Santos-Eggimann B. Healthcare and preventive services utilization of elderly Europeans 
with depressive symptoms. Journal of Affective Disorders 2008 ;105(1-3):247-52 
 
Postprint Version  Final draft post-refereeing 
Journal website  http://sciencedirect.com/science/journal/01650327 
Pubmed link  http://www.ncbi.nlm.nih.gov/pubmed/17509695 
DOI  10.1016/j.jad.2007.04.011 
 
 
Healthcare and preventive services utilization of elderly Europeans with depressive 
symptoms 
 
1,3Peytremann-Bridevaux I, 2Voellinger R, 1Santos-Eggimann B. 
 
1 Health Services Research Unit, Institute of Social and Preventive Medicine, University of 
Lausanne   
2 Health Care Evaluation Unit, Institute of Social and Preventive Medicine, University of 
Lausanne.   
3 Institute of Health Economics and Management, University of Lausanne. 
 
Corresponding author: 
 
I. Peytremann-Bridevaux, MD, MPH, DSc    
Institute of Social and Preventive Medicine 
17 Bugnon 
CH-1005 Lausanne, Switzerland 
Tel: #41 21 314 7284 
Fax: #41 21 314 7373 
Email: Isabelle.Peytremann-Bridevaux@chuv.ch 
 
Abstract  
Background:  Depressive symptoms are associated with increased healthcare utilization. 
However, it is unclear whether depressed individuals experience more or less frequent 
access to preventive services. Our goal was to investigate the association between 
depressive symptoms and both utilization of healthcare and preventive services. 
Methods: Baseline self-reported data (2004) from non-institutionalized individuals aged ≥ 50 
years participating in the Survey of Health, Ageing, and Retirement in Europe (SHARE) were 
used. Of 18’560 respondents to the baseline questionnaire, 13’580 answered the 
supplementary questionnaire, which included measures of preventive services. Healthcare 
utilization during the previous 12 months, including outpatient visits, medication, 
hospitalization, surgery, and home healthcare were assessed. Preventive service measures 
assessed the participation in influenza immunization and colorectal and breast cancer  
screening. Depression status was assessed with the EURO-D, a validated instrument for 
which a score > 3 defines clinically significant depressive symptoms. Logistic regressions 
were performed adjusting for age, gender, socioeconomic status, behavioral risk, chronic 
disease, disability, and country of residence.  
Results: The estimated prevalence of depressive symptoms was 28.2%. Depressive 
symptoms were associated with significantly greater use of all healthcare domains but not 
preventive services, with the exception of colorectal cancer screening. Similar trends were 
found for each country of residence and for both genders. 
Limitations: It was not known whether medical tests were used for screening or diagnostic 
purposes. 
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Conclusions: SHARE data suggest that patients with depressive symptoms are frequent 
users of healthcare but not preventive services. Low screening rates may reflect missed 
screening opportunities rather than a lack of screening opportunities.  
 
Key words: healthcare utilization; preventive services; depressive symptoms; population-
based survey. 
 
 
1. Introduction 
Depressive symptoms are a major public health problem because of their high 
prevalence, their detrimental effect on health (Braam et al., 2005) and their association with 
relatively frequent use of medical services (Bijl and Ravelli, 2000; Huang et al., 2000). In the 
elderly, the average prevalence of clinically relevant depressive syndromes (major and minor 
depression) is 13.5% (Beekman et al., 1999).  
Little research has been published regarding the receipt of preventive services by 
individuals presenting depressive symptoms, and the results of such research are discordant 
(Horvitz-Lennon et al., 2006, Lasser et al., 2003, Mangtani et al., 2005, Pirraglia et al., 2004; 
Werneke et al., 2006). The first aim of the present study was to assess the association 
between depressive symptoms and the use of health services. The second was to examine 
whether individuals with and without depressive symptoms received similar levels of 
preventive services.  
 
2. Methods 
2.1. Data Sources and Participants  
The Survey of Health, Ageing, and Retirement in Europe (SHARE) [Börsch-Supan et 
al., 2005a) included 10 countries in 2004 (Austria, Denmark, France, Germany, Greece, Italy, 
the Netherlands, Spain, Sweden, and Switzerland). Baseline data were collected from non-
institutionalized individuals aged >50 years using standardized face-to-face questionnaire-
based interviews (survey questionnaires available online: http://www.share-project.org/). 
Respondents to the baseline questionnaire (overall response rate: 61.8% [Börsch-Supan et 
al., 2005b]) were given a self-administered supplementary questionnaire that they had to 
return by mail. 
Of the 19’123 eligible respondents, 563 (2.9%) were excluded due to the absence of 
information regarding depressive symptoms (n=18’560), and 15’380 out of the latter (83%) 
responded to the supplementary questionnaire. These respondents were slightly more likely 
to be married, better educated, wealthier and more physically active. They also reported 
better subjective health and were less likely to present depressive symptoms. 
The study’s two samples consisted of the 18’560 individuals who answered the 
baseline questionnaire and the 15’380 individuals who answered both the baseline and 
supplementary questionnaire.  
 
2.2. Measures 
Except for preventive services information which was collected using the 
supplementary questionnaire, data were extracted from the baseline questionnaire. All 
measures were self-reported. 
The primary independent variable was the presence or absence of clinically 
significant depressive symptoms. This was defined by a score >3 on the EURO-D scale, a 
validated instrument developed in Europe [Prince et al., 1999], scale includes 12 items  (total 
score ranges between 0 and 12; higher scores indicate increased severity of depressive 
symptoms).  
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The main outcomes were measures of healthcare utilization during the previous 12 
months: use of medical care (in-outpatient, yes/no), number of ambulatory care visits, 
number of visits to general practitioners (among respondents with at least one ambulatory 
care visit), consultation of specialists (yes/no), hospital admission (yes/no), in-outpatient 
surgery (yes/no), number of medication taken >1x/week, use of home healthcare (yes/no), 
use of domestic help (yes/no), influenza vaccination (last year; individuals ≥ 65 years), 
participation in colorectal cancer (endoscopic screening; last 10 years; individuals ≥ 50 
years; no history of colorectal cancer), and breast cancer screening (mammogram; past 2 
years; women ≥ 50 years; no history of breast cancer). All outcomes were defined as binary 
variables. Data for the number of total and general practitioner ambulatory care visits and the 
number of medication taken were dichotomized into categories of high (> sample median) 
and low (≤ sample median) use. 
Potential confounders considered were: age, gender, marital status, years of 
education, household income adjusted for the size of the household, smoking, alcohol 
consumption, chronic diseases, disability and country of residence. 
 
2.3. Statistical analysis 
First we compared characteristics and healthcare use between groups using the chi-
squared test and ANOVA, for categorical and continuous variables, respectively. Then, to 
assess the odds of a given outcome in individuals with versus without depressive symptoms, 
multiple logistic regression models were constructed. The joint Wald test was used to 
evaluate interactions (depressive symptoms*country of residence, depressive 
symptoms*gender). Analyses were first performed on pooled data, and then for each country 
of residence, using Stata 8.0. None of the variables considered had missing data ≥ 2%.  
 
3. Results 
 
Twenty-eight percent of European men and women presented clinically significant 
depressive symptoms. The estimated prevalence ranged from 18.0% in Denmark to 37.6% in 
Spain (Table 1). Table 2 summarizes the characteristics of the study population. In the group 
with depressive symptoms, there was a greater proportion of women, individuals were less 
educated, reported more chronic diseases and worse subjective health.  
The crude health services utilization analyses (Table 3) show that a higher 
percentage of individuals with versus without depressive symptoms used healthcare, with the 
exception of breast cancer screening. The odds ratios (ORs) and 95% confidence interval 
(CI) for healthcare utilization and preventive services are presented in Table 4. Individuals 
with depressive symptoms were significantly more likely to be users of healthcare, and these 
relations were not explained by comorbidities. Indeed, the adjusted ORs for healthcare 
utilization ranged between 1.4 (95% CI 1.2-1.7) for any surgery to 2.2 (95% CI 1.9-2.6) for 
the use of >2 drug categories. While the presence of depressive symptoms was not  
associated with decreased or increased receipt of influenza immunization or breast cancer 
screening, the OR for colorectal cancer screening was significant. Adjustment for the number 
of outpatient visits or for rural residence did not change the point estimate or its significance.  
Country-level analyses showed similar trends for use of healthcare and preventive 
services. In addition, the associations between depressive symptoms and use of healthcare 
and preventive services did not statistically vary by country or gender (P-value >0.05 for 
interactions of depressive symptoms*country and depressive symptoms*gender).   
Additional analysis of healthcare utilization for the subgroup of respondents to the 
supplementary questionnaire yielded ORs similar to those reported in Table 4. 
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4. Discussion 
 
Our results show that depressive symptoms were independently and significantly 
associated with greater use of healthcare services. However, this increased number of 
contacts with the healthcare system (opportunities) did not affect the receipt of influenza 
immunization or breast cancer screening.  
Strengths of our study include a large database from 10 European countries and the 
use of standardized questionnaires and procedures. However, it has some limitations. For 
example, it was not known whether tests were performed for screening or diagnostic 
purposes. This could have affected our results, although in an unknown manner. In addition, 
the time windows for colorectal cancer screening were partly longer than those usually 
recommended (a 10-year limit was used in this study instead of recommended 
sigmoidoscopy every 5 years and colonoscopy every 10 years). This may have resulted in a 
non-differential misclassification across categories of depressive symptoms. Also, the cross-
sectional nature of the data precludes any definitive conclusions regarding causal 
relationships, and the use of self-reported data may have resulted in reporting and/or recall 
biases. 
Concordant with previous population-based studies from several countries (Beekman 
et al., 1997; Fischer et al., 2002; Himelhoch et al., 2004 McCracken et al., 2006; Rowan et 
al., 2002), our results reveal an association between depressive symptoms and general 
healthcare use, which was not fully explained by chronic diseases and/or disability. Together 
with the fact that most depressed individuals who visit their physician focus distress on 
somatic symptoms, these results suggest that depression may be independently associated 
with healthcare utilization.  
The findings of an association between depressive symptoms and preventive 
services are not consistent with previously published studies (Mangtani et al., 2005; Pirraglia 
et al., 2004; Werneke et al., 2006), and do not confirm the negative impact of depressive 
symptoms on receipt of preventive services (breast cancer screening and influenza 
immunization). There are several possible explanations for this difference. First, it may be 
difficult to access severely depressed individuals with population-based surveys. The slightly 
lower response rate (RR) to the supplementary questionnaire for participants with worse 
EURO-D scores supports the idea of a negative association between depression and survey 
participation. Also, the EURO-D cut-off >3 might have been too low to detect differences in 
receipt of preventive services between individuals with and without depressive symptoms. 
However, additional analyses using more categories of depressive symptoms did not support 
this hypothesis. Second, the more favorable health-related behaviors and profiles of the 
respondents versus non-respondents of the supplementary questionnaire could have 
attenuated differences between individuals with and without depressive symptoms, because 
they may have been too similar with regard to demographic and health characteristics. Third, 
the existence of competing demands might compel physicians to focus on depression 
management at the expense of health prevention, such that higher overall healthcare 
utilization occurs without increased use of preventive services. 
We are not aware of other studies evaluating the association between depression and 
colorectal screening, and suggest the following explanations for our finding of greater use of 
colorectal screening in depressed people. In the context of overall low use of a screening 
test, a long screening window could induce more colorectal cancer screening for individuals 
suffering from depressive symptoms, since they use more healthcare services. However, 
adjustment for the number of ambulatory care visits invalidates this explanation. The 
increased report of colorectal cancer screening might also be a consequence of the more 
frequent report of gastrointestinal symptoms (Garakani et al., 2003), and subsequent 
diagnostic endoscopies, for individuals with depressive symptoms. In contrast to breast 
cancer, which often presents without signs or symptoms, unspecific digestive complaints that 
precede colorectal cancer may prompt the performance of gastrointestinal endoscopies. As 
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physicians tend to focus more on health complaints than health promotion or prevention, this 
could explain some of the difference in receipt of preventive services concerning colorectal 
cancer versus breast cancer and influenza. 
 In conclusion, this study sheds light on the association between depressive 
symptoms and healthcare utilization and preventive services. As expected from the greater 
disease burden of individuals suffering from depressive symptoms, there was increased use 
of all dimensions of care. With the exception of colorectal cancer screening, this was not 
accompanied by an increase in receipt of preventive services. Healthcare professionals 
should be aware that low screening rates among individuals with depressive symptoms may 
be due to missed screening opportunities rather than a lack of screening opportunities. 
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 Table 1  
Estimated prevalence of depressive symptoms, by country  
(respondents to baseline questionnaire, n = 18’560) 
 
    
  Sample size Presence of depressive 
symptoms  
 
    
   % 
    
 Austria 1 893 19.7 
 Denmark 1 557 18.0 
 France 1 590 33.4 
 Germany 2 243 21.2 
 Greece 1 894 24.9 
 Italy 1 962 33.6 
 The Netherlands 2 213 21.2 
 Spain 1 735 37.6 
 Sweden 2 538 20.5 
 Switzerland 936 18.9 
    
    
 All 10 countries 18 560 28.2 
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 Table 2 
Characteristics of the participants, according to the presence/absence of depressive 
symptoms (respondents to the baseline questionnaire, n = 18’560) 
 
 
   
  Absence of depressive 
symptoms  
 
Presence of depressive 
symptoms  
 
 
  (n= 14’058) (n= 4’502)  
     
 Age, mean (SD) 64.4 (0.2) 67.6 (0.3)  
 Aged > 65 years 46.0% 56.4%  
     
 Women 48.3% 70.5%  
    
 Years of education, mean (SD) 10.4 (0.07) 8.0 (0.1)  
    
 Married or registered partnership 70.5% 55.9%  
    
 Employed 30.3% 16.4%  
    
 Currently smoking 19.2% 16.4%  
    
 Neither moderate nor vigorous 
physical activity 
8.0% 23.0%  
    
 Drinking >2 glasses of alcohol 5/6 
days a week 
17.4% 13.3%  
    
 Number of chronic diseases   
 0 30.9% 11.5%  
 1 33.5% 28.8%  
 2 or more 35.6% 59.7%  
    
 Number of  health complaints   
 0 36.6% 10.4%  
 1 35.1% 23.0%  
 2 or more 28.3% 66.6%  
    
 Fair or poor subjective health 
(versus excellent, very good, good) 
25.8% 60.9%  
   
 Difficulties in any of  5 activities of daily 
living 
5.6% 22.2%  
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 Table 3 
Description of health services utilization, according to the presence/absence of depressive symptoms  
 
     
  Absence of depressive 
symptoms 
Presence of depressive 
symptoms  
P-value 
     
 All participants (respondents to the baseline questionnaire
 (n= 18’560): 
   
 No utilization (neither out- nor in-patient) 13.8% 6.2% < 0.001 
 > 4 outpatient visits  52.0% 75.3% < 0.001 
 > 4 GP visits  46.0% 67.5% < 0.001 
 Any visit to specialists  93.1% 94.8% 0.07 
 > 2 drug categories  32.4% 60.5% < 0.001 
 Any hospitalization  11.3% 21.1% < 0.001 
 Any surgery  10.5% 15.7% < 0.001 
     
 Any home healthcare* 2.5% 8.7% < 0.001 
 Any domestic help*  2.2% 8.5% < 0.001 
     
 Only for respondents to the supplementary questionnaire 
 (n= 15’380): 
   
 Influenza immunization during past year (men and women, > 
65 years) 
52.8% 56.0% 0.12 
 Colorectal cancer screening during past 10 years: colono or 
sigmoido (men and women, no history of colorectal cancer) 
16.8% 19.2% 0.93 
 Breast cancer screening during past 2 years (women, no 
history of breast cancer) 
53.0% 48.0% 0.007 
     
 
*: Because home healthcare and domestic help questions were not asked to Greek and Swiss participants, those two countries were excluded from the 
analyses of these two outcomes. 
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 Table 4  
Health services utilization odds ratios (OR) and 95% confidence intervals (CI), reference 
category = absence of depressive symptoms 
 
   
  Crude 
 
Adjusted* 
  OR 95% 
CI 
OR 95% 
CI 
      
 All participants (respondents to the baseline 
questionnaire (n= 18’560): 
    
 No utilization (neither out- nor in-patient) 0.4 0.3-0.5 0.6 0.5-0.7
 > 4 outpatient visits 2.8 2.5-3.2 1.9 1.7-2.2
 > 4 GP visits 2.4 2.2-2.7 1.6 1.4-1.8
 Any visits to specialists 1.4 0.9-1.9 1.5 1.1-2.0
 > 2 drug categories 3.4 3.0-3.7 2.2 1.9-2.6
 Any hospitalization 2.1 1.8-2.4 1.6 1.4-1.9
 Any surgery 1.6 1.4-1.8 1.4 1.2-1.7
      
 Any home healthcare** 3.7 2.9-4.7 1.9 1.4-2.5
 Any domestic help** 4.1 3.3-5.2 1.8 1.4-2.5
      
 Only for respondents to the supplementary questionnaire 
(n= 15’380) : 
    
 Influenza immunization (men and women, > 65 years) 1.2 1.0-1.4 1.0 0.8-1.2
 Colorectal cancer screening: colono or sigmoido (men and 
women, no history of colorectal cancer) 
1.2  1.0-1.4 1.3 1.1-1.6
 Breast cancer screening (women, no history of breast cancer) 0.8 0.7-0.9 1.0 0.8-1.2
       
 
* : Adjusting as for age, gender, marital status, ppp-household income, education, smoking, alcohol consumption, 
presence of  
chronic diseases (> 2), presence of difficulties in activities of daily living, and country. 
**: Because home healthcare and domestic help questions were not asked to Greek and Swiss participants, those 
two countries were excluded from the analyses of these two outcomes. 
 
